Cyclophosphamide
STUDY00150697
Phase 2 small_molecule completed
Quick answer
Cyclophosphamide for Clinical Stage IV Cutaneous Melanoma AJCC v8 is a Phase 2 program (small_molecule) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IOVANCE BIOTHERAPEUTICS, INC.
- Indication
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed